Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

UCB, Inc. v. Actavis Laboratories UT, Inc., No. 21-1924 (Fed. Cir. Apr. 12, 2023)

Errata Correction sheet to a previously issued opinion
Errata
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 21-1924
Decided
April 12, 2023
Judge
—
Document
Errata
Length
2 pages
Download Opinion (PDF)

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit

June 16, 2023

ERRATA

Appeal No. 21-1924

UCB, INC., UCB PHARMA GMBH, LTS LOHMANN

THERAPIE-SYSTEME AG,

Plaintiffs-Appellants

v.

ACTAVIS LABORATORIES UT, INC.,

Defendant-Appellee Appeal No. 21-2336

UCB, INC., UCB PHARMA GMBH, LTS LOHMANN

THERAPIE-SYSTEME AG,

Plaintiffs-Appellants

v.

MYLAN TECHNOLOGIES INC.,

Defendant-Appellee

Decided: April 12, 2023

Precedential Opinion

22 UCB, INC. v. ACTAVIS LABORATORIES UT, INC. Please make the following change to the caption in the opinion and judgment issued April 12, 2023, and the order granting an extension of time issued May 8, 2023:1 UCB, INC., UCB PHARMA GMBH, LTS LOHMANN

THERAPIE-SYSTEME AG,

Plaintiffs-Appellants

v.

ACTAVIS LABORATORIES UT, INC.,

Defendant-Appellee

2021-1924

Appeal from the United States District Court for the District of Delaware in No. 1:19-cv-00474-KAJ, Circuit Judge Kent A. Jordan. UCB, INC., UCB PHARMA GMBH, LTS LOHMANN

THERAPIE-SYSTEME AG,

Plaintiffs-Appellants

v.

MYLAN TECHNOLOGIES INC.,

Defendant-Appellee

2021-2336

Appeal from the United States District Court for the District of Vermont in No. 2:19-cv-00128-cr, Judge Christina Reiss.

Footnotes

  1. ↩ 1 The originating tribunal information has been corrected to state that Appeal No. 2021-2336 originated from the United States District Court for the District of Vermont.

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

UCB, Inc. v. Actavis Laboratories UT, Inc., No. 21-1924 (Fed. Cir. Apr. 12, 2023).

Record ID
CAFC-21-1924-20230616
Permalink
https://patentcasewatch.com/opinions/CAFC-21-1924-20230616

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: Federal Circuit opinions and orders · retrieved August 15, 2026 · Report an error

Other documents in this case